Patent ID: 7541464

Claim:
A compound of formula I: wherein R1 and R2 are selected from the group consisting of H and (C1-C6)-alkyl, or R1 and R2 taken together with the carbon atom to which they are attached form a, (C3-C6)-cycloalkyl; R3 is selected from the group consisting of H, F, Cl, Br, NO2, CN, CF3, SCH3, (C1-C6)-alkyl, (C2-C6)-alkenyl, and (C1-C4)-alkylene-O—(C1-C4)-alkyl R4 is H or (C1-C6)-alkyl, R5 is selected from the group consisting of H, (C1-C6)-alkyl, and (C1-C6) alkylene-phenyl, R6 is selected from the group consisting of H, F, Cl, Br, CN, CF3, SCH3, (C1-C6)-alkyl, and (C1-C4)-alkylene-O—(C1-C4)-alkyl; R7 is selected from the group consisting of (C1-C6)alkyl, (C1-C4)alkylene-O—(C1-C4)alkyl, (C1-C6)alkylene-phenyl, (C1-C4)alkylene-O—(C1-C4)alkylene-phenyl, (C3-C6)cycloalkyl, (C2-C6)alkenyl, phenyl, O-phenyl, (C1-C6)alkylene-S(O) n —(C1-C6)alkyl, (C1-C6)alkylene-NR10R11, (C1-C6)alkylene-CONR10R11, (C1-C6)alkylene-SO2NR10R11, (C1-C6)alkylene-NR10SO2-(C1-C6)alkyl, (C1-C6)alkylene-OCONR10R11, (C1-C6)alkylene-NR10COR11, and (C1-C6)alkylene-NR10CONR11, wherein alkyl may be optionally substituted with one or more fluorine or phenyl atoms and where n may be 0, 1 or 2; R8 and R9 are independently selected from the group consisting of H, F, Cl, Br, CF 3 , OCF 3 , (C 1 -C 6 )-alkyl, O—(C 1 -C 6 )-alkyl, SCF 3 , SF 5 , OCHF 2 , OCH 2 F, OCF 2 -CHF 2 , O-phenyl, OH, and NO 2 ; R10 and R11 are independently selected from the group consisting of H,(C1-C6)alkyl and (C3-C6)-cycloalkyl wherein the alkyl and cycloalkyl are optionally substituted with one to three F or heteroaryl; or R10 and R11 may together with the N atom to which they are attached form a 4, 5 or 6-membered saturated, partly saturated or unsaturated heterocycle ring wherein a carbon (C) atom may be replaced by N, O, S, SO or SO 2 ; and X is —CH2- or —CH2CH2-; or a pharmaceutically acceptable salt thereof.